Treatment outcomes of standard (high dose) cisplatin and non‐standard chemotherapy for locally advanced head and neck cancer

INTRODUCTION: Concurrent chemoradiotherapy with high‐dose (HD) cisplatin is the standard treatment for locally advanced head and neck squamous cell carcinoma (LA‐HNSCC). Due to the higher treatment‐related adverse effects with standard therapy, alternative regimens (non‐standard therapy), namely, lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamgeer, Muhammad, Coleman, Andrew, McDowell, Lachlan, Giddings, Charles, Safdar, Adnan, Sigston, Elizabeth, Wang, Yang, Subramaniam, Ashwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875652/
https://www.ncbi.nlm.nih.gov/pubmed/35792145
http://dx.doi.org/10.1002/cnr2.1674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875652/
https://www.ncbi.nlm.nih.gov/pubmed/35792145
http://dx.doi.org/10.1002/cnr2.1674

Ejemplares similares